Previous 10 | Next 10 |
ROCKVILLE, Md., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, presented updated preliminary safety and effica...
ROCKVILLE, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced that the company and its clinic...
Rexahn Pharmaceuticals ( RNN +0.9% ) has received a notice of allowance from the USPTO regarding its application for method-of-use patents protecting RX-3117. The patent, when issued, will be in effect until 2036. More news on: Rexahn Pharmaceuticals Inc Read more ...
ROCKVILLE, Md., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, announced that the U.S. Patent and Trademark Of...
NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SeaWorld Entertainment, Inc. (NYSE:SEAS), Rigel Pharmaceuticals, Inc. (NA...
Gainers: Boxlight Corporation (NASDAQ: BOXL ) +47% . Microbot Medical (NASDAQ: MBOT ) +33% . Regional Health Properties (NYSEMKT: RHE ) +33% . Blink Charging (NASDAQ: BLNK ) +27% . iFresh (NASDAQ: IFMK ) +18% . Planet Green Holdings (NYSEMKT: PLAG ) +15% . Daxor Corporation (NY...
Rexahn Pharmaceuticals (NYSEMKT: RNN ) prices its public offering of 10.75M common stock and warrants to purchase same amount of common shares at a combined offering price of $0.80 per share and related warrant, for gross proceeds of ~$8.6M. More news on: Rexahn Pharmaceuticals Inc, Heal...
Rexahn Pharmaceuticals (NYSEMKT: RNN ) -36% on announcing equity offering. More news on: Rexahn Pharmaceuticals Inc, Selecta Biosciences, Staffing 360 Solutions, Inc., Stocks on the move, , Read more ...
ROCKVILLE, Md., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced the pricing of an underwritten public offering of 10,750,000 shares of its common stock and warrants to purchase up to 10,750,000 shares of its common stock. Each share of com...
ROCKVILLE, Md., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. The offering is subject to...
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Inc. Company Name:
RNN Stock Symbol:
NYSE Market:
Rexahn Pharmaceuticals Inc. Website:
ROCKVILLE, Md., May 28, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced that it will voluntarily transfe...
ROCKVILLE, Md., May 13, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced financial results for the first ...
ROCKVILLE, Md. and SUZHOU, China, April 16, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage, biopharmaceutical company focused on oncology, and BioSense Global LLC, a New Jersey- and Suzhou, China-based biopharmaceutical company, today announced ...